A Mixed Picture: Philips' Revenue Grows but Faces Bumps

Philips just reported a mixed bag of results. Even though business grew in some areas, profits dipped in others. Order intake—a fancy term for new business requests—climbed 6%, while sales went up 4%. That’s good news, especially since the economy is still shaky. But here’s the catch: while some parts of the company thrived, others struggled to keep costs under control.The Diagnosis & Treatment division did well. Sales hit €1. 85 billion, and profits improved slightly. Image-guided therapy, which uses tech to help doctors see inside the body, was a big winner. But precision diagnosis, where tools help pinpoint diseases, saw a small drop. Meanwhile, Connected Care—a sector dealing with remote patient monitoring—earned €1. 06 billion but saw profits shrink due to rising costs. The Personal Health segment, selling things like fitness trackers and sleep apnea devices, was the star. It grew 9% and boosted profits by a solid margin. The bigger picture shows Philips sticking to its long-term goals. It expects sales to grow by 3-4. 5% by 2026, but critics might wonder if costs like tariffs and inflation will keep dragging down profits. The company also aims for a free cash flow of €1. 3-1. 5 billion, which could help balance things out.